Amarin Sues Dr. Reddy's In U.S. Court For Infringing Vascepa Patents
This article was originally published in PharmAsia News
Executive Summary
Dr. Reddy's Laboratories has been named in a U.S. court suit by Ireland-based Amarin Pharma, which charged the India drug maker infringed on its patent for the drug Vascepa (icosapent) for severe hypertriglyceridemia.